ibrutinib,venetoclax
janssen,abbvie,roche
['lymphoma', 'lymsm', 'cll']
4 yr pfs 94.5% with ibr+ven first-line #cll #lymphoma #lymsm #ash22 
Lymphoma Program Director, Colorado Blood Cancer Institute #lymphoma #lymsm #celltherapy #CART #autoimmune #BMT @CBCIDocs @ColoradoBlood ?????? opinions my own